Cord Blood America

Biotechnology ResearchNevada, United States11-50 Employees

Cord Blood America, Inc., operating through its wholly owned subsidiary CorCell Companies, Inc., collects, tests, processes, and cryopreserves umbilical cord blood to support potential future stem cell therapy. The company is based in Las Vegas, Nevada, and operates within the biotechnology research sector, focusing on cord blood banking. Cryogenically preserved cord blood stem cells have been used to treat 75 major diseases, including leukemia and other immune or metabolic disorders, illustrating the potential value of this resource.

Its primary customers are families seeking to preserve cord blood at birth for possible future therapies. As a small to mid-sized biotechnology firm, it occupies a specialized position in the cord blood banking landscape.

Sign up for free to view info

Email Format Employee directory